CA3190433A1 - Methods of making cholic acid derivatives and starting materials therefor - Google Patents

Methods of making cholic acid derivatives and starting materials therefor

Info

Publication number
CA3190433A1
CA3190433A1 CA3190433A CA3190433A CA3190433A1 CA 3190433 A1 CA3190433 A1 CA 3190433A1 CA 3190433 A CA3190433 A CA 3190433A CA 3190433 A CA3190433 A CA 3190433A CA 3190433 A1 CA3190433 A1 CA 3190433A1
Authority
CA
Canada
Prior art keywords
compound
formula
optionally substituted
alkyl
oxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3190433A
Other languages
English (en)
French (fr)
Inventor
J. Gregory Reid
Jayachandra P. REDDY
Bernhard J. Paul
SK Samad HOSSAIN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandhill One LLC
Original Assignee
Sandhill One LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandhill One LLC filed Critical Sandhill One LLC
Publication of CA3190433A1 publication Critical patent/CA3190433A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C07J41/0061—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
CA3190433A 2020-08-21 2021-08-11 Methods of making cholic acid derivatives and starting materials therefor Pending CA3190433A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063068498P 2020-08-21 2020-08-21
US63/068,498 2020-08-21
PCT/US2021/045467 WO2022039983A2 (en) 2020-08-21 2021-08-11 Methods of making cholic acid derivatives and starting materials therefor

Publications (1)

Publication Number Publication Date
CA3190433A1 true CA3190433A1 (en) 2022-02-24

Family

ID=80269315

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3190433A Pending CA3190433A1 (en) 2020-08-21 2021-08-11 Methods of making cholic acid derivatives and starting materials therefor

Country Status (7)

Country Link
US (1) US11384116B2 (cg-RX-API-DMAC7.html)
EP (1) EP4200311A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023539828A (cg-RX-API-DMAC7.html)
CN (1) CN115884978A (cg-RX-API-DMAC7.html)
AU (1) AU2021328142A1 (cg-RX-API-DMAC7.html)
CA (1) CA3190433A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022039983A2 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023081658A2 (en) 2021-11-02 2023-05-11 Sandhill One, Llc High purity non-animal derived tudca
US20250206771A1 (en) * 2022-03-25 2025-06-26 Suzhou Entech New-Material Technology Co., Ltd 7-ketolithocholic acid intermediate, synthesis method therefor, and application thereof
CN116836214B (zh) * 2022-03-25 2024-07-09 苏州恩泰新材料科技有限公司 一种7-酮石胆酸中间体的合成方法和应用
CN116836213B (zh) * 2022-03-25 2026-05-05 苏州恩泰新材料科技有限公司 一种7-酮石胆酸中间体及其合成方法和应用
CN115819491A (zh) * 2022-12-22 2023-03-21 江苏佳尔科药业集团股份有限公司 7-酮基石胆酸及熊去氧胆酸的合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1204429B (it) 1986-01-09 1989-03-01 Blaschim Spa Riduzione stereoselettiva in acidi biliari
US5595996A (en) 1994-10-25 1997-01-21 Merck & Co., Inc. 7-substituted 4-aza cholanic acid derivatives and their use
EP1775304A4 (en) * 2004-07-13 2010-04-28 Mitsubishi Chem Corp PROCESS FOR THE PRODUCTION OF STEROIDS
CN101018802A (zh) * 2004-07-13 2007-08-15 三菱化学株式会社 甾类化合物的制备方法
CN105936897A (zh) 2009-11-30 2016-09-14 细胞制药有限公司 新的7β-羟类固醇脱氢酶及它们的用途
WO2012047495A2 (en) * 2010-09-27 2012-04-12 Kythera Biopharmaceuticals, Inc. Methods for preparing synthetic bile acids and compositions comprising the same
BR112018001869A2 (pt) * 2015-07-30 2018-09-18 Intercept Pharmaceuticals Inc método para preparação de ácidos biliares e derivados dos mesmos
CN108348533A (zh) 2015-11-06 2018-07-31 英特塞普特医药品公司 制备奥贝胆酸及其衍生物的方法
HUP1800439A2 (hu) * 2018-12-20 2020-06-29 Equip Test Kft Csatlakozószerkezet optikai vezetékek csatlakoztatására, valamint krimpelõ eszköz és kinyomó eszköz ahhoz
CN111072744B (zh) 2019-12-03 2021-09-14 江苏佳尔科药业集团股份有限公司 一种以ba为原料合成熊去氧胆酸的方法

Also Published As

Publication number Publication date
EP4200311A4 (en) 2024-11-20
EP4200311A2 (en) 2023-06-28
JP2023539828A (ja) 2023-09-20
US11384116B2 (en) 2022-07-12
CN115884978A (zh) 2023-03-31
US20220056070A1 (en) 2022-02-24
AU2021328142A1 (en) 2023-03-16
WO2022039983A3 (en) 2022-03-31
WO2022039983A2 (en) 2022-02-24

Similar Documents

Publication Publication Date Title
US11384116B2 (en) Methods of making cholic acid derivatives and starting materials therefor
ES2669052T3 (es) Método de preparación de acetato de ulipristal y sus intermedios
CN106459136B (zh) 一种奥贝胆酸的制备方法
CN111560045A (zh) 一种以ba为原料合成石胆酸的方法
CN104402862B (zh) 艾立替尼的制备方法
US20220298202A1 (en) Methods of making cholic acid derivatives and starting materials therefor
US20220372065A1 (en) Synthesis of cholesterol and vitamin d3 from phytosterols
CN104610359A (zh) 一种制备磷酸特地唑胺的关键中间体及其制备方法
WO2021020998A1 (ru) Способ получения роксадустата
WO2018010651A1 (zh) 一种奥贝胆酸及其中间体的制备方法
EP3838894A1 (en) Method for producing intermediate useful for synethesis of sglt inhibitor
CN106518944A (zh) 甲基泼尼松的制备方法
RU2689335C1 (ru) Средства для ингибирования фермента тирозил-ДНК-фосфодиэстеразы 1 на основе желчных кислот
EP0338065B1 (fr) Derives de la 19-nor progesterone, leur preparation et leur utilisation
CN101429224B (zh) 1,4-双烯-6-亚甲基甾体化合物的合成方法及中间体
JP5107262B2 (ja) ケノデオキシコール酸の精製方法
WO2023081166A1 (en) Stereoselective steroidal reductions
RU2500671C1 (ru) ПРОИЗВОДНОЕ 1',2',3'-ТРИМЕТОКСИБЕНЗО[4',5':4,5]-6,7-ДИГИДРОЦИКЛОГЕПТА-[3,2-f]-1H-1-МЕТИЛИНДОЛА И ЕГО ПРИМЕНЕНИЕ
CN114133421A (zh) 一种β-鼠胆酸的制备方法
KR20080027368A (ko) 네비볼롤의 제조방법
CN106478757A (zh) 一种3α,7α‑二羟基‑6α‑乙基胆烷酸的制备方法
WO1995016699A1 (en) Steroid derivative
JP2020528068A (ja) ステロイド系誘導体fxrアゴニストの製造方法
KR100982720B1 (ko) 4-카르바모일-1-β-D-리보푸라노실이미다졸륨-5-올레이트의 생산을 위한 중간체로서의 2-아미노말론아미드의제조방법
MX2012009251A (es) Un proceso para introducir un enlace doble en la posicion 15, 16 de un esteroide.

Legal Events

Date Code Title Description
MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD

Year of fee payment: 3

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20240802

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20240802

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - STANDARD

Year of fee payment: 4

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250801

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250801

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260206

B12 Application deemed to be withdrawn, abandoned or lapsed

Free format text: ST27 STATUS EVENT CODE: N-1-6-B10-B12-B301 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO A REQUEST FOR EXAMINATION NOTICE

Effective date: 20260407

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260709